Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92123


This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.


Inclusion Criteria: - Histologic evidence of EE defined as greater than 20 eosinophils per hpf on esophageal biopsy - Ages 1 yrs and older - Ability to continue the same diet that the patient was on at the time of EGD with biopsy Exclusion Criteria: - Adverse reaction or allergy to budesonide - Pregnancy - Chronic diseases requiring immunomodulatory therapy - Use of swallowed topical corticosteroids for EE within the past 3 months - Use of systemic steroids 2 months prior to study entry - Upper gastrointestinal bleed within 4 months of study entry - Chronic use of medications that predispose to upper gastrointestinal bleeding including non-steroidal anti-inflammatory medications or anticoagulants - Evidence of adrenal suppression prior to study entry - Evidence of concurrent eosinophilic gastritis, enteritis, colitis, or proctitis - Recent changes in asthma or allergic rhinitis therapy for 3 months



Primary Contact:

Principal Investigator
Ranjan Dohil, MD

Backup Contact:


Location Contact:

San Diego, California 92123
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.